Cargando…
A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma
Background: Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous disease that can have profound differences in survival outcomes. A variety of powerful prognostic factors and models have been constructed; however, the development of more accurate prognosis prediction and targeted tre...
Autores principales: | Xu, Hong, Li, Yuhang, Jiang, Yanan, Wang, Jinhuan, Sun, Huimeng, Wu, Wenqi, LV, Yangyang, Liu, Su, Zhai, Yixin, Tian, LinYan, Li, Lanfang, Zhao, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237400/ https://www.ncbi.nlm.nih.gov/pubmed/35774514 http://dx.doi.org/10.3389/fgene.2022.827840 |
Ejemplares similares
-
Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022) -
Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023) -
Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023) -
Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review
por: Tian, Linyan, et al.
Publicado: (2023) -
Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma
por: Wu, Wenqi, et al.
Publicado: (2023)